David Caudell to Precursor Cell Lymphoblastic Leukemia-Lymphoma
This is a "connection" page, showing publications David Caudell has written about Precursor Cell Lymphoblastic Leukemia-Lymphoma.
Connection Strength
0.598
-
Caudell D, Harper DP, Novak RL, Pierce RM, Slape C, Wolff L, Aplan PD. Retroviral insertional mutagenesis identifies Zeb2 activation as a novel leukemogenic collaborating event in CALM-AF10 transgenic mice. Blood. 2010 Feb 11; 115(6):1194-203.
Score: 0.339
-
Alexander PM, Caudell DL, Kucera GL, Pladna KM, Pardee TS. The novel phospholipid mimetic KPC34 is highly active against preclinical models of Philadelphia chromosome positive acute lymphoblastic leukemia. PLoS One. 2017; 12(6):e0179798.
Score: 0.143
-
Pardee TS, Stadelman K, Jennings-Gee J, Caudell DL, Gmeiner WH. The poison oligonucleotide F10 is highly effective against acute lymphoblastic leukemia while sparing normal hematopoietic cells. Oncotarget. 2014 Jun 30; 5(12):4170-9.
Score: 0.116